HER2-EXPRESSING SOLID TUMORS
Clinical trials for HER2-EXPRESSING SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new HER2-EXPRESSING SOLID TUMORS trials appear
Sign up with your email to follow new studies for HER2-EXPRESSING SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first study in people to test an experimental drug called MT-304 for advanced cancers that have a protein called HER2. The main goals are to check if the drug is safe, find the best dose, and see if it helps control the cancer. About 60 adults will receive MT-304 by i…
Matched conditions: HER2-EXPRESSING SOLID TUMORS
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
One-Shot gene therapy trial aims to turn body into Cancer-Fighting factory
Disease control Recruiting nowThis first-in-human trial is testing a new gene therapy called VNX-202 for people with HER2-positive cancers. The therapy uses a single IV infusion to teach the liver to continuously produce cancer-fighting proteins, potentially eliminating the need for repeated treatments. Resea…
Matched conditions: HER2-EXPRESSING SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Vironexis Biotherapeutics Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC